HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katelyn Dunigan Selected Research

Aurothioglucose (Gold 50)

1/2019Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia.
1/2018Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katelyn Dunigan Research Topics

Disease

3Bronchopulmonary Dysplasia
01/2019 - 01/2018
3Lung Injury
01/2019 - 10/2018
2Hyperoxia
01/2019 - 01/2018
1Critical Illness (Critically Ill)
10/2018
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
10/2018

Drug/Important Bio-Agent (IBA)

3ThioredoxinsIBA
01/2019 - 01/2018
2AntioxidantsIBA
01/2019 - 10/2018
2Aurothioglucose (Gold 50)IBA
01/2019 - 01/2018
2NF-E2-Related Factor 2IBA
10/2018 - 01/2018
1Glutathione (Reduced Glutathione)IBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1SeleniumIBA
10/2018
1Trace Elements (Biometals)IBA
10/2018